215 HUMAN OSTEOARTHRITIS CHONDROCYTES EXPRESS THE CALCITONIN RECEPTOR T. Segovia-Silvestre  by Sondergaard, B.C. et al.
Poster Presentations / Osteoarthritis and Cartilage 18, Supplement 2 (2010) S45–S256 S101
Regarding galectin mRNA levels in human chondrocytes (n=8), we found
expression in the order: LGALS1 (0.36±0.13) > LGALS3 (0.18±0.06) >
LGALS8 (0.09±0.03) > LGALS9 (LGALS7 <0.00004).
Conclusions: Here, we have portrayed for the ﬁrst time the complete
glycome of human chondrocytes out of minute amounts of cultured cells
(100,000 cells). IL-1β and TNF-α induce a range of speciﬁc alterations in
chondrocyte glycoproteins supporting the hypothesis that the chondro-
cyte glycobiology might be of relevance for malfunctioning cell-matrix
interactions or altered galectin function under disease conditions.
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Purpose: Our previous studies showed that human chondrocytes adjust
their glucose transport capacity and facilitative glucose transporter (GLUT)-
1 content in response to high and low extracellular glucose concentrations.
OA chondrocytes, however, fail to downregulate GLUT-1 content and glu-
cose transport when exposed to high extracellular glucose concentrations.
The consequent intracellular glucose accumulation causes prolonged oxida-
tive stress which can compromise chondrocyte functions. The mechanisms
by which chondrocytes sense the extracellular glucose concentration and
subsequently adjust GLUT-1 content are unknown. Functional ATP-sensitive
potassium [K(ATP)] channels were demonstrated in equine chondrocytes
and in other cells were shown to play an important role as metabolic
sensors. In pancreatic β cells, high extracellular glucose causes these chan-
nels to close, increasing the intracellular calcium concentration and insulin
secretion. Thus, we hypothesized that K(ATP) channels may function as
metabolic sensors in chondrocytes, generating the signals that lead to
adjustment of GLUT-1 content. To test this hypothesis, we evaluated the
ability of speciﬁc blockers (glibenclamide) and openers (levcromakalin) of
the K(ATP) channels to modulate GLUT-1 content in normal and OA human
chondrocytes.
Methods: Normal (N=5, 31-59 years old, mean=44) and OA (N=6, 60-72
years old, mean=65) human chondrocytes were obtained from multi-organ
donors or patients undergoing total knee replacement surgery, respectively,
at the University Hospitals of Combra. Non-proliferating chondrocyte cul-
tures were treated with glibenclamide or levcromakalin for 18h. GLUT-1
content and actin levels were evaluated in total cell extracts by western
blot.
Results: No signiﬁcant difference was found between basal GLUT-1 content
in normal and OA chondrocytes. Treatment of normal chondrocytes with
10, 20 and 100 nM glibenclamide signiﬁcantly decreased GLUT-1 con-
tent (61.8±10.1%, 57.9±11.3% and 61.2±7.9%, respectively) while 20 μM
(112±23.7%) had no effect, relatively to untreated cells. In the OA group,
however, none of the glibenclamide concentrations tested signiﬁcantly
affected GLUT-1 content. Treatment with 0.5 μM levcromakalin had no
signiﬁcant effect on GLUT-1 content either in normal (96±24.8%) or OA
(108±20.4%) chondrocytes.
Conclusions: These results suggest that closure of K(ATP) channels is
involved in GLUT-1 downregulation in human chondrocytes, consequently
modulating glucose transport. In OA chondrocytes, however, this process
seems to be impaired and thus may compromise their ability to adjust
glucose transport to metabolic needs.
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Purpose: A growing body of evidence suggests that calcitonin (CT) has a
direct chondroprotective effect against degenerative joint disease in artic-
ular cartilage. The expression of the calcitonin receptor by chondrocytes is
currently a matter of debate. In this study, we sought to test the hypothesis
that human chondrocytes do express the calcitonin receptor.
Methods: We worked with fresh primary chondrocyte samples isolated
from arthroplasty cartilage specimens dissected from osteoarthritis pa-
tients. We established a dedicated reverse transcription polymerase chain
reaction (RT-PCR) protocol followed by a nested PCR assay aiming at
amplifying the full coding region of the calcitonin receptor mRNA (CALCR).
We optimized a western blotting protocol for characterizing calcitonin
receptor protein (CTR) immunoreactivity in chondrocyte samples using
human osteoclasts as positive controls. We validated an immunochemical
procedure for localizing CTR in both primary and in situ chondrocytes.
Results: We ampliﬁed and sequenced four different allelic variants of
CALCR in four patients. We detected a protein reacting against different
CTR antibodies in four other patients. The molecular weight of the chon-
drocyte protein corresponds to that expressed by human osteoclasts. The
plasma membrane of primary chondrocytes was intensely stained with one
of the CTR antibodies validated by western blotting.
Conclusions: Human articular cartilage chondrocytes express both the
mRNA and protein molecules of the calcitonin receptor. These ﬁndings sig-
nal the calcitonin receptor as a new pharmacological target in osteoarthritis
treatment.
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Purpose: investigate the effect of leptin on cartilage destruction in os-
teoarthritis.
Methods: The release of proteoglycan and collagen was assessed in bovine
cartilage explant cultures, while collagenolytic activities and gelatinolytic
activity in culture supernates were determined by bioassay and gelatin
zymography. The expression and production of MMPs was analyzed by
real-time reverse transcription polymerase chain reaction (RT-PCR). Sig-
nalling pathway activation was studied by immunoblotting. Levels of leptin
in the supernatants from cultured osteoarthritic (OA) joint infrapatellar fat
pad was measured by ELISA.
Results: Leptin signiﬁcantly induced collagen release from bovine cartilage,
by up-regulation of collagenolytic and genatinolytic activity. When added
in combination with IL-1, a marked synergistic and a dose-dependent
increased cartilage collagen release and enzyme activity was observed.
In cultured chondrocytes, leptin induced MMP-1 and MMP-13 expression
with a concomitant activation STATs -1, -3, -5, MAPK (JNK, Erk, p38), Akt
and NFκB pathways. Blockade of PI3K, P38, Erk and AKT pathway with
selective inhibitors signiﬁcantly reduced MMP-1 and MMP-13 expression
in chondrocytes, and reduced collagen release induced by leptin or leptin
+ IL-1 in bovine cartilage. Furthermore, we found that supernatants from
cultured OA joint infrapatellar fat pad contained leptin and can signiﬁcant
induce cartilage proteoglycan and collagen release from cartilage, and
increase MMP-1 and MMP-13 expression chondrocytes. An anti-leptin anti-
body was able to partially suppress the effects of the fat conditioned media
with respect to the induction of the collagenases by human chondrocytes.
Conclusions: This study demonstrates that leptin acts as a pro-
inﬂammatory cytokine with a catabolic role on cartilage metabolism
via the up-regulation and activation of proteolytic enzymes via PI3K, Akt,
Erk and STATs signalling pathways. Moreover, our data suggests that the
infrapatellar fat pad in arthritic joints is a local producer of leptin which
may contribute to inﬂammatory and degenerative processes in cartilage
metabolism, providing a mechanistic link between obesity and OA.
